Amneal Pharmaceuticals Ownership | Who Owns Amneal Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Amneal Pharmaceuticals Ownership Summary


Amneal Pharmaceuticals is owned by 47.33% institutional investors, 46.44% insiders, and 6.23% retail investors. Vanguard group is the largest institutional shareholder, holding 5.72% of AMRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.79% of its assets in Amneal Pharmaceuticals shares.

AMRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAmneal Pharmaceuticals47.33%46.44%6.23%
SectorHealthcare Stocks 41.87%10.80%47.33%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.16%11.89%61.94%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group17.95M5.72%$179.73M
Blackrock funding, inc. /de14.07M4.49%$140.88M
Rubric capital management lp12.33M3.93%$123.47M
Tpg gp a12.33M3.93%$123.41M
Blackrock11.28M3.67%$71.64M
Dimensional fund advisors lp5.43M1.73%$54.36M
Nantahala capital management4.22M1.35%$42.29M
Geode capital management4.03M1.29%$40.39M
State street3.97M1.27%$39.78M
Neuberger berman group3.72M1.18%$37.18M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tpg gp a12.33M6.72%$123.41M
Tucker asset management1.11M1.99%$8.80M
Phocas financial1.29M1.67%$12.87M
Blackbarn capital partners lp2.19M1.57%$21.92M
Nantahala capital management4.22M1.47%$42.29M
Rubric capital management lp12.33M1.39%$123.47M
Jackson creek investment advisors232.49K0.67%$2.33M
Pfm health sciences, lp355.82K0.27%$3.56M
Virtus etf advisers35.92K0.24%$359.57K
Convergence investment partners96.92K0.22%$970.14K

Top Buyers

HolderShares% AssetsChange
Blackrock11.28M0.00%2.12M
Blackrock funding, inc. /de14.07M0.00%1.94M
Assenagon asset management2.15M0.03%1.40M
Allspring global investments1.14M0.02%1.06M
Morgan stanley3.50M0.00%1.01M

Top Sellers

HolderShares% AssetsChange
Fosun---1.72M
Woodline partners lp---1.50M
Hennessy advisors---1.50M
Blackbarn capital partners lp2.19M1.57%-1.26M
Cubist systematic strategies---684.12K

New Positions

HolderShares% AssetsChangeValue
Pfm health sciences, lp355.82K0.27%355.82K$3.56M
Australiansuper pty323.44K0.01%323.44K$3.24M
Envestnet asset management160.61K0.00%160.61K$1.61M
Capula management145.30K0.01%145.30K$1.45M
Norges bank86.20K0.00%86.20K$547.37K

Sold Out

HolderChange
Global retirement partners-1.00
Newedge advisors-5.00
Global financial private client-12.00
Stephens consulting-45.00
Wr wealth planners-59.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20252431.25%148,491,3234.94%472.33%131-5.76%7325.86%
Jun 30, 2025235-0.42%141,337,0205.14%452.41%138-2.13%565.66%
Mar 31, 202523618.00%134,653,2606.93%432.62%14214.52%5335.90%
Dec 31, 20241997.57%124,789,717-12.50%401.90%12132.97%41-28.07%
Sep 30, 2024183-0.54%141,484,8992.04%452.27%91-14.15%5624.44%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv5.61M1.79%-124.32K
Vanguard US Total Market Shares ETF4.36M1.39%-
Vanguard Small Cap Index4.20M1.34%-13.19K
iShares Russell 2000 ETF3.65M1.16%-
Vanguard Small Cap Value Index Inv2.70M0.86%10.25K
Vanguard Institutional Extnd Mkt Idx Tr1.63M0.52%-712.55K
Fidelity Small Cap Index1.50M0.48%-98.79K
Hennessy Cornerstone Growth Investor1.50M0.48%-171.20K
Columbia Small Cap Value II1.19M0.38%65.17K
Columbia Small Cap Value and Inflection1.19M0.38%65.17K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 12, 2025Shah Nikita Executive Vice PresidentSell$1.57M
Aug 27, 2025Kiely John-Sell$295.36K
Aug 22, 2025Shah Nikita Executive Vice PresidentSell$1.11M
Aug 25, 2025Shah Nikita Executive Vice PresidentSell$60.23K
Aug 20, 2025BOYER ANDREW S Executive Vice PresidentSell$2.62M

Insider Transactions Trends


DateBuySell
2025 Q4-1
2025 Q3-11
2025 Q2-7
2025 Q1-10
2024 Q4-5

AMRX Ownership FAQ


Who Owns Amneal Pharmaceuticals?

Amneal Pharmaceuticals shareholders are primarily institutional investors at 47.33%, followed by 46.44% insiders and 6.23% retail investors. The average institutional ownership in Amneal Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.16%, which Amneal Pharmaceuticals exceeds.

Who owns the most shares of Amneal Pharmaceuticals?

Amneal Pharmaceuticals’s largest shareholders are Vanguard group (17.95M shares, 5.72%), Blackrock funding, inc. /de (14.07M shares, 4.49%), and Rubric capital management lp (12.33M shares, 3.93%). Together, they hold 14.14% of Amneal Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amneal Pharmaceuticals?

Yes, BlackRock owns 3.67% of Amneal Pharmaceuticals, totaling 11.28M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 71.64M$. In the last quarter, BlackRock increased its holdings by 2.12M shares, a 23.11% change.

Who is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tpg gp a is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 6.72% of its assets in 12.33M Amneal Pharmaceuticals shares, valued at 123.41M$.

Who is the top mutual fund holder of Amneal Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Amneal Pharmaceuticals shares, with 1.79% of its total shares outstanding invested in 5.61M Amneal Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools